FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Breakthroughs in Cancer Research and Treatmentnews2023-07-01T11:00:12+00:00July 1st, 2023|The New York Times|
Suddenly, It Looks Like We’re in a Golden Age for Medicinenews2023-06-23T15:29:07+00:00June 23rd, 2023|The New York Times|
Cancer Drug Advancements Give New Hope to Metastatic Patientsnews2023-06-16T19:26:50+00:00June 16th, 2023|The New York Times|
What to Know About the New Treatment for Hot Flashesnews2023-05-12T23:07:14+00:00May 12th, 2023|The New York Times|
Public Health Lessons Learned From the Coronavirus Pandemicnews2023-05-11T09:00:23+00:00May 11th, 2023|The New York Times|
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Diseasenews2023-05-03T21:57:13+00:00May 3rd, 2023|The New York Times|
F.D.A. Approves New Nasal Spray for Migrainesnews2023-03-10T18:37:27+00:00March 10th, 2023|The New York Times|
Start-Up Paradigm Raises $200 Million to Speed Up Drug Trialsnews2023-01-27T10:00:17+00:00January 27th, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
